Market Leadership Fziomed is a global leader in postsurgical adhesion prevention with nearly one million patients treated since 2002, demonstrating extensive experience and credibility that can be leveraged to expand client trust and credibility in new markets.

Innovative Technology With its patented synthetic dual-polymer technology made in the USA, Fziomed offers advanced adhesion barrier products, positioning the company as a technically innovative solution provider suitable for hospitals seeking cutting-edge surgical biomaterials.

Global Reach Distributing products across more than 70 countries, Fziomed's broad international presence indicates strong potential for partnerships and sales expansion into emerging and established markets worldwide.

Strategic Growth Recent leadership appointments, including new President and Board members with extensive industry experience, suggest a strategic focus on scaling operations and increasing market penetration in the surgical biomaterials sector.

Surgical Specialization Fziomed specializes in postsurgical adhesion prevention across various surgical disciplines such as spine, gynecology, and orthopedics, presenting targeted opportunities to offer complementary solutions to healthcare providers focusing on these high-volume specialties.